Search by Drug Name or NDC

    NDC 25021-0816-30 Leucovorin Calcium 350 mg/17.5mL Details

    Leucovorin Calcium 350 mg/17.5mL

    Leucovorin Calcium is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is LEUCOVORIN CALCIUM.

    Product Information

    NDC 25021-0816
    Product ID 25021-816_ff2ba160-e2f9-4ab9-9e67-2409f02c923e
    Associated GPIs 21755040102160
    GCN Sequence Number 044534
    GCN Sequence Number Description leucovorin calcium VIAL 350 MG INJECTION
    HIC3 V1I
    HIC3 Description CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS
    GCN 87553
    HICL Sequence Number 001063
    HICL Sequence Number Description LEUCOVORIN CALCIUM
    Brand/Generic Generic
    Proprietary Name Leucovorin Calcium
    Proprietary Name Suffix n/a
    Non-Proprietary Name leucovorin calcium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 350
    Active Ingredient Units mg/17.5mL
    Substance Name LEUCOVORIN CALCIUM
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Folate Analog [EPC], Folic Acid [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200855
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0816-30 (25021081630)

    NDC Package Code 25021-816-30
    Billing NDC 25021081630
    Package 1 VIAL in 1 CARTON (25021-816-30) / 17.5 mL in 1 VIAL
    Marketing Start Date 2012-09-15
    NDC Exclude Flag N
    Pricing Information N/A